Loading clinical trials...
Loading clinical trials...
Exploring Two CBT-based Treatments as Interventions for Emotion Dysregulation in Misophonia
While the investigators continue to work on better understanding Misophonia, it is also important to identify treatments that can help people who are currently suffering. Further, it is important that the treatments provided are acceptable to the people who receive them. In this study, participants will complete one of two treatments the investigators believe can help manage symptoms of Misophonia: The Unified Protocol or process-based therapy. Both treatments will use evidence-based psychological principles (e.g., managing attention or behavior) in a flexible manner and will focus on developing skills to help reduce the distress and impairment associated with Misophonia. The aims of this study are (1) to explore the acceptability and feasibility of these treatments for individuals who experience Misophonia and (2) to examine whether these treatments help reduce symptoms associated with Misophonia.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Duke University Medical Center
Durham, North Carolina, United States
Start Date
September 11, 2020
Primary Completion Date
November 21, 2022
Completion Date
November 21, 2022
Last Updated
November 25, 2022
12
ACTUAL participants
Unified Protocol for Transdiagnostic Treatment of Emotional Disorders
BEHAVIORAL
Process-based Cognitive Behavioral Therapy
BEHAVIORAL
Lead Sponsor
Duke University
NCT07271485
NCT07220941
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06493825